Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter. T50.2X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM T50.2X5A became effective on October 1, 2018.
ICD-10 is a diagnostic coding system implemented by the World Health Organization. In this section we list out codes for diuretics and ICD Code Y54.5.
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter. T50.2X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM T50.2X5A became effective on October 1, 2018.
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter. T50.2X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
T50.2X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM T50.2X5A became effective on October 1, 2019. This is the American ICD-10-CM version of T50.2X5A - other international versions of ICD-10 T50.2X5A may differ.
Encounter for other specified aftercareICD-10 code Z51. 89 for Encounter for other specified aftercare is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code E87. 70 for Fluid overload, unspecified is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes.
ICD-10 uses only a single code for individuals who meet criteria for hypertension and do not have comorbid heart or kidney disease. That code is I10, Essential (primary) hypertension.
ICD-10 code R33. 9 for Retention of urine, unspecified is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
With respect to fluid overload and CCF, Coding Matters Volume 7 No 3 under Congestive heart failure advises it is not necessary to code fluid overload in a patient with CHF.
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.
Long-term medicine Any medicine you have to take for three or more months to control symptoms or to prevent complications from a condition. Examples of conditions that might require long-term medicine include: high blood pressure, high cholesterol, diabetes, arthritis, heart conditions, and long-term pain.
I16. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM I16.
Z codes are for use in any healthcare setting. Z codes may be used as either a first-listed (principal diagnosis code in the inpatient setting) or secondary code, depending on the circumstances of the encounter.
0.
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional) Approximate Synonyms. Diuretic overdose. Poisoning by diuretic. Poiso ning by thiazide diuretic. Thiazide diuretic overdose.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
T50.2 Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics. T50.2X Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics.
Acetazolamide is prescribed to treat excess fluid accumulation due to congestive heart failure.
This medication is a diuretic agent, prescribed for fluid retention in people with congestive heart failure, liver disease or kidney disorder.
This medication is an osmotic diuretic, prescribed for increased intracranial pressure, eye pressure, to maintain urine flow in kidney failure patients, and promotion of urinary excretion of toxic materials.
This medication is a thiazide diuretic, prescribed for high blood pressure and fluid retention caused by various conditions.
Hydrochlorothiazide and Triamterene. This combination medication contains potassium-sparing diuretic and thiazide diuretic, prescribed for essential hypertension, and edema due to low potassium level in body.
It is also used to treat glaucoma or increased pressure in the eye, seizures or epilepsy, mountain sickness, periodic paralysis or muscle weakness, and to reduce the increased pressure in areas surrounding the brain and spinal cord.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
T50.2 Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics. T50.2X Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics.